Kenneth C. Anderson

Also affiliated with Dana-Farber Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 78 papers. Top paper: “Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma”.

Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma

New England Journal of Medicine(2022)10.1056/nejmoa2204925

N/A

6.2DataRank · unranked

474 citations

Susanna Jacobus, Edie Weller, Hani Hassoun, Sagar Lonial, Noopur Raje +51 more

Initial genome sequencing and analysis of multiple myeloma

Nature(2011)10.1038/nature09837

N/A

1.1DataRank · unranked

1438 citations

Michael S. Lawrence, Jonathan J. Keats, Kristian Cibulskis, Carrie Sougnez, Anna C. Schinzel +51 more

A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry

Blood Advances(2020)10.1182/bloodadvances.2019000491

N/A

1.1DataRank · unranked

31 citations

Niels Weinhold, Gregory Song, Kristin A. Rand, David Van Den Berg, Amie E. Hwang +65 more

Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myeloma

Nature Communications(2024)10.1038/s41467-024-45561-z

N/A

1.0DataRank · unranked

35 citations

Lijie Xing, Jiang Li, Kenneth Wen, Ning Liu, Yuntong Liu +17 more

Future cancer research priorities in the USA: a Lancet Oncology Commission

The Lancet Oncology(2017)10.1016/s1470-2045(17)30698-8

N/A

0.801DataRank · unranked

208 citations

Chi Van Dang, David B. Agus, Brian M. Alexander, Kenneth C. Anderson, Alan Ashworth +64 more

Anti-Myeloma Activity of a Novel Glutaminase Inhibitor CB-839

Blood(2014)10.1182/blood.v124.21.3439.3439

N/A

0.515DataRank · unranked

7 citations

Durgadevi Ravillah, Arghya Ray, Yan Song, Nikhil C. Munshi, Paul G. Richardson +3 more

Long-Term Follow-up of CALGB (Alliance) 100001: Autologous Followed by Nonmyeloablative Allogeneic Transplant for Multiple Myeloma

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2020.03.028

N/A

0.351DataRank · unranked

6 citations

Vera J. Suman, Kouros Owzar, Katelyn Santo, Don M. Benson, Thomas C. Shea +10 more

Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone

medRxiv(2024)10.1101/2024.04.19.24306082

N/A

0.343DataRank · unranked

6 citations

Michelle P. Aranha, Robert Redd, Michael Timonian, Sophie Magidson, Elizabeth D. Lightbody +17 more

Targeting of CD38 by the Tumor Suppressor miR-26a Serves as a Novel Potential Therapeutic Agent in Multiple Myeloma

Cancer Research(2020)10.1158/0008-5472.can-19-1077

N/A

0DataRank · unranked

37 citations

Huimin Liu, Chuanfeng Fang, Chen Li, Fjorela Xhyliu, Hayley Dysert +16 more

YWHAE/14-3-3ε expression impacts the protein load, contributing to proteasome inhibitor sensitivity in multiple myeloma

Blood(2020)10.1182/blood.2019004147

N/A

0DataRank · unranked

27 citations

Mariateresa Fulciniti, Mehmet Samur, Matthew Ho, Shuhui Deng, Lanting Liu +20 more

Biological correlates to support a clinical role for tagraxofusp, a novel targeted therapy directed to CD123, in combination with pomalidomide and dexamethasone, to target plasmacytoid dendritic cells in poor-risk patients with multiple myeloma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e20537

N/A

0DataRank · unranked

1 citations

Arghya Ray, Yan Song, Arturo Olguin, Janice Chen, Christopher Brooks +4 more

A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci

UNC Libraries(2020)10.17615/hhzp-hr83

N/A

0DataRank · unranked

0 citations

Elad Ziv, Wendy Cozen, Andrew F. Olshan, Nathaniel Rothman, Thomas G. Martin +95 more

Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma

Nature Communications(2021)10.1038/s41467-021-21177-5

N/A

0DataRank · unranked

414 citations

Mariateresa Fulciniti, Anıl Aktaş Samur, Abdul Hamid Bazarbachi, Yu‐Tzu Tai, Rao Prabhala +10 more

Bortezomib Induces Anti–Multiple Myeloma Immune Response Mediated by cGAS/STING Pathway Activation

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-21-0047

N/A

0DataRank · unranked

139 citations

Eugenio Morelli, Mehmet Samur, Cirino Botta, Teru Hideshima, Giada Bianchi +13 more

Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma

Leukemia(2021)10.1038/s41375-021-01301-6

N/A

0DataRank · unranked

75 citations

Fabrizio Accardi, Teru Hideshima, Yu‐Tzu Tai, Rao Prabhala, Aaron Shambley +6 more

Lysine Demethylase 5A Is Required for MYC-Driven Transcription in Multiple Myeloma

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-20-0108

N/A

0DataRank · unranked

40 citations

Paul M.C. Park, Tingjian Wang, Berkley E. Gryder, Daisuke Ogiya, Keiji Kurata +25 more

A 3D‐Bioprinted Multiple Myeloma Model

Advanced Healthcare Materials(2021)10.1002/adhm.202100884

N/A

0DataRank · unranked

42 citations

Zongyi Wang, Jun Li, Yan Song, Manuel Everardo Mondragón Pérez, Zixuan Wang +7 more

Harnessing the Immune System Against Multiple Myeloma: Challenges and Opportunities

Frontiers in Oncology(2021)10.3389/fonc.2020.606368

N/A

0DataRank · unranked

39 citations

Nicola Amodio, Annamaria Gullà, Kenneth C. Anderson, Leona Yamamoto

Promising Antigens for the New Frontier of Targeted Immunotherapy in Multiple Myeloma

Cancers(2021)10.3390/cancers13236136

N/A

0DataRank · unranked

39 citations

Lijie Xing, Kenneth C. Anderson, Yu‐Tzu Tai, Shih‐Feng Cho

The HCK/BTK inhibitor KIN-8194 is active in MYD88-driven lymphomas and overcomes mutated BTKCys481 ibrutinib resistance

Blood(2021)10.1182/blood.2021011405

N/A

0DataRank · unranked

28 citations

Jinhua Wang, Li Tan, Manit Munshi, Xia Liu, Amanda Kofides +17 more

ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironment

Science Advances(2021)10.1126/sciadv.abg2697

N/A

0DataRank · unranked

26 citations

Teru Hideshima, Lijie Xing, Su Wang, Wenrong Zhou, Mehmet Samur +15 more

IgM-MM is predominantly a pre–germinal center disorder and has a distinct genomic and transcriptomic signature from WM

Blood(2021)10.1182/blood.2021011452

N/A

0DataRank · unranked

21 citations

Hervé Avet‐Loiseau, Raphaël Szalat, Anıl Aktaş Samur, Zachary R. Hunter, Masood A. Shammas +9 more

Identification of novel anti-tumor therapeutic target via proteomic characterization of ubiquitin receptor ADRM1/Rpn13

Blood Cancer Journal(2021)10.1038/s41408-020-00398-9

N/A

0DataRank · unranked

12 citations

Ting Du, Arghya Ray, Krishan Chauhan, Mehmet Samur, Nikhil C. Munshi +3 more

Development of PRPK Directed Phthalimides

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.11.30.469594

N/A

0DataRank · unranked

0 citations

Takashi Mizutani, Teru Hideshima, Nicholas E. Vangos, Tinghu Zhang, Kenneth C. Anderson +3 more

Long Noncoding RNA RROL Provides Chromatin Scaffold for MYC-WDR82 Interaction to Impact Lipid Metabolism and Tumor Cell Growth in Multiple Myeloma

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.12.08.471297

N/A

0DataRank · unranked

0 citations

Mariateresa Fulciniti, Mehmet Samur, Caroline F. Ribeiro, León Wert-Lamas, Jon E. Henninger +27 more

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

Blood(2022)10.1182/blood.2022015851

N/A

0DataRank · unranked

1528 citations

Elaine S. Jaffe, James R. Cook, Leticia Quintanilla‐Martínez, Steven H. Swerdlow, Kenneth C. Anderson +68 more

Bispecific antibodies in multiple myeloma treatment: A journey in progress

Frontiers in Oncology(2022)10.3389/fonc.2022.1032775

N/A

0DataRank · unranked

57 citations

Tsung‐Jang Yeh, Kenneth C. Anderson, Yu-Tzu Tai, Shih‐Feng Cho

γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation

Blood Cancer Journal(2022)10.1038/s41408-022-00716-3

N/A

0DataRank · unranked

54 citations

Tengteng Yu, Liang Lin, Lijie Xing, Shih‐Feng Cho, Kenneth Wen +9 more

Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

Leukemia(2022)10.1038/s41375-022-01711-0

N/A

0DataRank · unranked

33 citations

Vijai Joseph, Yolanda Benavente, Nicola J. Camp, Alexandra Nieters, Zhaoming Wang +95 more

Influence of Tyrosine Kinase Inhibition on Organic Anion Transporting Polypeptide 1B3-Mediated Uptake

Molecular Pharmacology(2022)10.1124/molpharm.121.000287

N/A

0DataRank · unranked

17 citations

Kenneth C. Anderson, Elizabeth R. Hayden, Kyle Z. Pasquariello, Alice A. Gibson, Shichen Shen +6 more

Improving NK cell function in multiple myeloma with NKTR-255, a novel polymer-conjugated human IL-15

Blood Advances(2022)10.1182/bloodadvances.2022007985

N/A

0DataRank · unranked

25 citations

Jessica Encinas, Laetitia Pierre-Louis, Yao Yao, Yan Xu, Shidai Mu +9 more

In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors

Blood Cancer Journal(2022)10.1038/s41408-022-00759-6

N/A

0DataRank · unranked

25 citations

Mariateresa Fulciniti, Hervé Avet‐Loiseau, Michael Lopez, Sanika Derebail, Jill Corre +8 more

A new role for the SRC family kinase HCK as a driver of SYK activation in MYD88 mutated lymphomas

Blood Advances(2022)10.1182/bloodadvances.2021006147

N/A

0DataRank · unranked

15 citations

Xia Liu, Amanda Kofides, Nickolas Tsakmaklis, Maria Luisa Guerrera, Zachary R. Hunter +18 more

Identification and validation of ecto-5' nucleotidase as an immunotherapeutic target in multiple myeloma

Blood Cancer Journal(2022)10.1038/s41408-022-00635-3

N/A

0DataRank · unranked

15 citations

Yan Song, Ting Du, Leutz Buon, Yu‐Tzu Tai, Dharminder Chauhan +2 more

Dysfunctions of innate and adaptive immune tumor microenvironment in Waldenström macroglobulinemia

International Journal of Cancer(2022)10.1002/ijc.34405

N/A

0DataRank · unranked

9 citations

Gábor Beke, Zachary R. Hunter, Teru Hideshima, Ludmila M. Flores, Tatiana Zeleznikova +10 more

Promises and Challenges of Immunogenic Chemotherapy in Multiple Myeloma

Cells(2022)10.3390/cells11162519

N/A

0DataRank · unranked

5 citations

Delaney Vinaixa, Marcello Turi, Eugenio Morelli, Kenneth C. Anderson, Annamaria Gullà +1 more

Characterizing dry mass and volume changes in human multiple myeloma cells upon treatment with proteotoxic and genotoxic drugs

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.18.484926

N/A

0DataRank · unranked

3 citations

Maria Moscvin, Seungeun Oh, Tianzeng Chen, Wonshik Choi, Benjamin Evans +9 more

Author Correction: Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma

Leukemia(2022)10.1038/s41375-022-01588-z

N/A

0DataRank · unranked

0 citations

Shruti Bhatt, Kenneth Wen, Zuzana Chyra, Geoffrey Fell, Yu‐Tzu Tai +7 more

High-dose melphalan treatment significantly increases mutational burden at relapse in multiple myeloma

Blood(2023)10.1182/blood.2022017094

N/A

0DataRank · unranked

48 citations

Marco Roncador, Anıl Aktaş Samur, Mariateresa Fulciniti, Abdul Hamid Bazarbachi, Raphaël Szalat +14 more

BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3668

N/A

0DataRank · unranked

33 citations

Mehmet Samur, Priscilla Liow, Kenneth Wen, Leona Yamamoto, Jiye Liu +7 more

BCMA-targeted bortezomib nanotherapy improves therapeutic efficacy, overcomes resistance, and modulates the immune microenvironment in multiple myeloma

Blood Cancer Journal(2023)10.1038/s41408-023-00955-y

N/A

0DataRank · unranked

23 citations

Jiye Liu, Kenneth Wen, Keiji Kurata, Mariateresa Fulciniti, Annamaria Gullà +3 more

Development of a Covalent Inhibitor of c-Jun N-Terminal Protein Kinase (JNK) 2/3 with Selectivity over JNK1

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.2c01834

N/A

0DataRank · unranked

27 citations

Yao Liu, Yang Gao, Qixiang Geng, Deepak Gurbani, Lianbo Li +17 more

Ubiquitin receptor PSMD4/Rpn10 is a novel therapeutic target in multiple myeloma

Blood(2023)10.1182/blood.2022017897

N/A

0DataRank · unranked

20 citations

Yan Song, Arghya Ray, Xueping Wan, Yao Yao, Mehmet Samur +11 more

Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma

Blood Cancer Journal(2023)10.1038/s41408-023-00787-w

N/A

0DataRank · unranked

17 citations

Anna James-Bott, Mark A. Tye, Leona Yamamoto, Mehmet Samur, Yu‐Tzu Tai +24 more

Heterogeneity of B cell lymphopoiesis in patients with premalignant and active myeloma

JCI Insight(2023)10.1172/jci.insight.159924

N/A

0DataRank · unranked

15 citations

Dana Cholujová, Gábor Beke, Teru Hideshima, Lubos Klucar, Merav Leiba +6 more

Immunomodulation of NK, NKT and B/T cell subtypes in relapsed/refractory multiple myeloma patients treated with pomalidomide along with velcade and dexamethasone and its association with improved progression-free survival

Frontiers in Oncology(2023)10.3389/fonc.2023.1271807

N/A

0DataRank · unranked

10 citations

William E. Pierceall, Mehmet Samur, Lakshmi B. Potluri, Kevin Hong, Teresa Peluso +18 more

Characterizing dry mass and volume changes in human multiple myeloma cells upon treatment with proteotoxic and genotoxic drugs

Clinical and Experimental Medicine(2023)10.1007/s10238-023-01124-y

N/A

0DataRank · unranked

7 citations

Maria Moscvin, Seungeun Oh, Tianzeng Chen, Wonshik Choi, Benjamin Evans +9 more

Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics

Blood Cancer Journal(2023)10.1038/s41408-023-00791-0

N/A

0DataRank · unranked

3 citations

Zuzana Chyra, Sigitas Verselis, Morgan O'Keefe, Jacquelyn Cobb, Ivane Abiatari +10 more

Investigation into aberrant B cell repertoire in myeloma on humoral immunity and patient survival.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.8016

N/A

0DataRank · unranked

2 citations

Hannah Seah, Vaishnavi Reddy Bade, Arthur Krogman, Shree Acharya, Andreea Negroiu +13 more

Data from Up-Regulation of c-Jun Inhibits Proliferation and Induces Apoptosis via Caspase-Triggered c-Abl Cleavage in Human Multiple Myeloma

(2023)10.1158/0008-5472.c.6495389.v1

N/A

0DataRank · unranked

0 citations

Marc S. Raab, Giovanni Tonon, Martin Sattler, Daniela Barilà, Jing Zhang +8 more

Data from Up-Regulation of c-Jun Inhibits Proliferation and Induces Apoptosis via Caspase-Triggered c-Abl Cleavage in Human Multiple Myeloma

(2023)10.1158/0008-5472.c.6495389

N/A

0DataRank · unranked

0 citations

Marc S. Raab, Giovanni Tonon, Martin Sattler, Daniela Barilà, Jing Zhang +8 more

Data from Cisplatin-Mediated Upregulation of APE2 Binding to MYH9 Provokes Mitochondrial Fragmentation and Acute Kidney Injury

(2023)10.1158/0008-5472.c.6512529.v1

N/A

0DataRank · unranked

0 citations

Chun Yang, Tânia Amorim, Mohsin Maqbool, Jenny J. Lin, Chen Li +23 more

Data from The Monoclonal Antibody nBT062 Conjugated to Cytotoxic Maytansinoids Has Selective Cytotoxicity Against CD138-Positive Multiple Myeloma Cells In vitro and In vivo

(2023)10.1158/1078-0432.c.6517504

N/A

0DataRank · unranked

0 citations

Teru Hideshima, Mariateresa Fulciniti, Robert J. Lutz, Hiroshi Yasui, Yutaka Okawa +16 more

Data from Preclinical Studies in Support of Defibrotide for the Treatment of Multiple Myeloma and Other Neoplasias

(2023)10.1158/1078-0432.c.6517722

N/A

0DataRank · unranked

0 citations

Cécile Rouleau, Cinara Echart, Krishna Menon, Beverly A. Teicher, Maria Distaso +6 more

Data from Preclinical Studies in Support of Defibrotide for the Treatment of Multiple Myeloma and Other Neoplasias

(2023)10.1158/1078-0432.c.6517722.v1

N/A

0DataRank · unranked

0 citations

Cécile Rouleau, Cinara Echart, Krishna Menon, Beverly A. Teicher, Maria Distaso +6 more

Data from The Monoclonal Antibody nBT062 Conjugated to Cytotoxic Maytansinoids Has Selective Cytotoxicity Against CD138-Positive Multiple Myeloma Cells In vitro and In vivo

(2023)10.1158/1078-0432.c.6517504.v1

N/A

0DataRank · unranked

0 citations

Teru Hideshima, Mariateresa Fulciniti, Robert J. Lutz, Hiroshi Yasui, Yutaka Okawa +16 more

Data from BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression

(2023)10.1158/1078-0432.c.6530600.v1

N/A

0DataRank · unranked

0 citations

Su Wang, Jiye Liu, Tengteng Yu, Hailin Chen, Kenneth Wen +11 more

Data from Bortezomib Induces Anti–Multiple Myeloma Immune Response Mediated by cGAS/STING Pathway Activation

(2023)10.1158/2643-3230.c.6550306

N/A

0DataRank · unranked

0 citations

Eugenio Morelli, Mehmet Samur, Cirino Botta, Teru Hideshima, Giada Bianchi +13 more

Data from Lysine Demethylase 5A Is Required for MYC-Driven Transcription in Multiple Myeloma

(2023)10.1158/2643-3230.c.6550489.v1

N/A

0DataRank · unranked

0 citations

Paul M.C. Park, Tingjian Wang, Berkley E. Gryder, Daisuke Ogiya, Keiji Kurata +25 more

Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myeloma

Blood(2024)10.1182/blood.2023022777

N/A

0DataRank · unranked

19 citations

Eugenio Morelli, Megan Johnstone, Marcello Turi, Mehmet Samur, Cirino Botta +24 more

A novel small molecule inhibitor of CD73 triggers immune-mediated multiple myeloma cell death

Blood Cancer Journal(2024)10.1038/s41408-024-01019-5

N/A

0DataRank · unranked

17 citations

Ting Du, Xueping Wan, Yan Song, Sindhu C Pillai, Md. Abu Musa +15 more

Improving Collection and Analysis of Overall Survival Data

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0919

N/A

0DataRank · unranked

17 citations

Nicole Gormley, Ruixiao Lu, Anup Amatya, George D. Demetri, Keith T. Flaherty +12 more

DAMPening Tumor Immune Escape: The Role of Endoplasmic Reticulum Chaperones in Immunogenic Chemotherapy

Antioxidants and Redox Signaling(2024)10.1089/ars.2024.0558

N/A

0DataRank · unranked

11 citations

Marcello Turi, Pietro Folino, Cole Clericuzio, Francesca Barello, Tallya Maciel +3 more

Venetoclax resistance leads to broad resistance to standard-of-care anti-MM agents, but not to immunotherapies

Blood Advances(2024)10.1182/bloodadvances.2023012298

N/A

0DataRank · unranked

4 citations

Sanika Derebail, Vera Joy Weiler, Jessica Fong Ng, Elena Maroto-Martín, Madhumouli Chatterjee +15 more

Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

UNC Libraries(2024)10.17615/1b8m-w521

N/A

0DataRank · unranked

0 citations

Heather J. Sutherland, Paul Brennan, Laurie Burdett, Nicola J. Camp, Xiaosheng Wu +95 more

A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry

UNC Libraries(2024)10.17615/ct6n-5k64

N/A

0DataRank · unranked

0 citations

David V. Conti, J Mehta, Thomas G. Martin, Kenneth C. Anderson, Song, G.C. +65 more

International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma

Journal of Clinical Oncology(2025)10.1200/jco-24-01893

N/A

0DataRank · unranked

142 citations

Faith E. Davies, Mehmet Samur, Jill Corre, Mattia D’Agostino, Martin Kaiser +41 more

Deeper response predicts better outcomes in high-risk-smoldering-myeloma: results of the I-PRISM phase II clinical trial

Nature Communications(2025)10.1038/s41467-024-55308-5

N/A

0DataRank · unranked

14 citations

Michelle P. Aranha, Robert Redd, Michael Timonian, Sophie Magidson, Elizabeth D. Lightbody +17 more

Deciphering neutrophil dynamics in the focal lesion tumor microenvironment to overcome immunosuppression in multiple myeloma

Blood(2025)10.1182/blood.2025028963

N/A

0DataRank · unranked

8 citations

Qi Yan, Saeed Daneshmandi, Romain Lannes, Eriko Katsuta, Jee Eun Choi +14 more

CRISPR-Cas13d functional transcriptomics reveals widespread isoform-selective cancer dependencies on lncRNAs

Blood(2025)10.1182/blood.2025028746

N/A

0DataRank · unranked

5 citations

Anıl Aktaş Samur, Domenico Maisano, Claire Gao, Vanessa Favasuli, Dimitrios Papaioannou +17 more

Targeting Siglec–sialic acid checkpoint to reverse immune dysfunction mediated by plasmacytoid dendritic cells in myeloma

Blood Advances(2025)10.1182/bloodadvances.2025015980

N/A

0DataRank · unranked

1 citations

Leutz Buon, Xueping Wan, Ting Du, Yan Song, Sindhu C Pillai +5 more

Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression

Journal of Clinical Oncology(2020)10.1200/jco.20.00437

N/A

0DataRank · unranked

182 citations

Romanos Sklavenitis‐Pistofidis, Jihye Park, Robert Redd, Benny Zhitomirsky, Andrew Dunford +31 more

Timing the initiation of multiple myeloma

Nature Communications(2020)10.1038/s41467-020-15740-9

N/A

0DataRank · unranked

165 citations

Venkata D. Yellapantula, Daniel Leongamornlert, Niccolò Bolli, Guy Ledergor, Ferran Nadeu +21 more

A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma

Blood Advances(2020)10.1182/bloodadvances.2020002827

N/A

0DataRank · unranked

416 citations

Hervé Avet‐Loiseau, Kenneth C. Anderson, Paola Neri, Bruno Paiva, Mehmet Samur +11 more

The JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implications

Blood(2020)10.1182/blood.2019004332

N/A

0DataRank · unranked

89 citations

Jiye Liu, Hiroto Ohguchi, Keiji Kurata, Mehmet Samur, Yu‐Tzu Tai +5 more

Cisplatin-Mediated Upregulation of APE2 Binding to MYH9 Provokes Mitochondrial Fragmentation and Acute Kidney Injury

Cancer Research(2020)10.1158/0008-5472.can-20-1010

N/A

0DataRank · unranked

44 citations

Chun Yang, Tânia Amorim, Mohsin Maqbool, Jenny Lin, Chen Li +23 more

BCMA-Targeting Therapy: Driving a New Era of Immunotherapy in Multiple Myeloma

Cancers(2020)10.3390/cancers12061473

N/A

0DataRank · unranked

54 citations

Liang Lin, Lijie Xing, Yuyin Li, Tengteng Yu, Kenneth C. Anderson +2 more

VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivo

Blood Cancer Journal(2020)10.1038/s41408-020-00378-z

N/A

0DataRank · unranked

44 citations

Bharat K. R. Chaganty, Liang Lin, Lijie Xing, Boopathy Ramakrishnan, Kenneth Wen +18 more